bauschretinarx.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /EPiServer/CMS/ Disallow: | ||
Meta Tags
| Title | BAUSCH AND LOMB Portfolio |
| Description | BAUSCH + LOMB PHARMACEUTICAL RETINA BAUSCH AND LOMB Portfolio home page for MACUGEN (pegaptanib sodium injection), RETISERT (fluocinolone acetonide intravitreal implant) 0.59 mg and VISUDYNE (verteporfin for |
| Keywords | MACUGEN (pegaptanib sodium injection), RETISERT - fluocinolone acetonide intravitreal implant - 0.59 mg, VISUDYNE - verteporfin for injection, Bausch and Lomb |
Server Information
| WebSite | |
| Host IP | 217.114.85.70 |
| Location | Sweden |
Related Websites
| Site | Rank |
More to Explore
bauschretinarx.com Valuation
|
US$8,203,341
Last updated: 2023-05-16 00:13:31
bauschretinarx.com has Semrush global rank of 1,290,243. bauschretinarx.com has an estimated worth of US$ 8,203,341, based on its estimated Ads revenue. bauschretinarx.com receives approximately 946,540 unique visitors each day. Its web server is located in Sweden, with IP address 217.114.85.70. According to SiteAdvisor, bauschretinarx.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$8,203,341 |
| Daily Ads Revenue | US$7,573 |
| Monthly Ads Revenue | US$227,170 |
| Yearly Ads Revenue | US$2,726,034 |
| Daily Unique Visitors | 63,103 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| bauschretinarx.com. | A | 3600 | IP: 217.114.85.70 |
| bauschretinarx.com. | NS | 86400 | NS Record: ns5.markmonitor.com. |
| bauschretinarx.com. | NS | 86400 | NS Record: ns7.markmonitor.com. |
| bauschretinarx.com. | NS | 86400 | NS Record: ns3.markmonitor.com. |
| bauschretinarx.com. | NS | 86400 | NS Record: ns2.markmonitor.com. |
| bauschretinarx.com. | NS | 86400 | NS Record: ns6.markmonitor.com. |
| bauschretinarx.com. | NS | 86400 | NS Record: ns4.markmonitor.com. |
| bauschretinarx.com. | NS | 86400 | NS Record: ns1.markmonitor.com. |
HtmlToTextCheckTime:2023-05-16 00:13:31
| ADDITIONAL PRODUCTS BAUSCH + LOMB SURGICAL SITE FOR PATIENTS Menu Close × HOME XIPERE ® retisert ® About RETISERT ® Efficacy & Safety Ordering & Patient Assistance Additional Resources Prescribing Information Important Safety Information visudyne ® About VISUDYNE ® Efficacy & Safety Ordering & Patient Assistance Additional Resources Prescribing Information Important Safety Information ADDITIONAL PRODUCTS BAUSCH + LOMB SURGICAL SITE FOR PATIENTS XIPERE ® Prescribing Information RETISERT ® Prescribing Information VISUDYNE ® Prescribing Information BAUSCH + LOMB PHARMACEUTICAL RETINA PORTFOLIO Explore these products to help you manage patients in your practice The Bausch + Lomb Pharmaceutical Retina Portfolio is available to help you meet your patients’ therapeutic needs. We know you have many choices when it comes to treating your patients. Personalized patient assistance programs are available from Bausch + Lomb for these treatment options. Learn how FOCUS ON ACCESS™ (FOA) Program can |
HTTP Headers
HTTP/1.0 301 Moved Permanently Location: http://www.bauschretinarx.com/ Server: BigIP Connection: Keep-Alive Content-Length: 0 HTTP/1.1 301 Moved Permanently Date: Sun, 16 Jan 2022 08:43:22 GMT Content-Type: text/html; charset=UTF-8 Content-Length: 154 Connection: close Location: https://www.bauschretinarx.com/ X-Powered-By: ASP.NET Set-Cookie: ARRAffinity=c630d7865fd9d96e97469db1c0ac782d81300c6686e3446c2aa660f3597f950b;Path=/;HttpOnly;Domain=www.bauschretinarx.com CF-Cache-Status: DYNAMIC Server: cloudflare CF-RAY: 6ce60e4a1d945c38-FRA HTTP/2 200 date: Sun, 16 Jan 2022 08:43:23 GMT content-type: text/html; charset=utf-8 cache-control: private vary: Accept-Encoding set-cookie: ASP.NET_SessionId=5dgu4ciuldwr30bsntzuki3d; path=/; HttpOnly; SameSite=Lax x-aspnetmvc-version: 5.2 x-aspnet-version: 4.0.30319 request-context: appId=cid-v1:65ea7503-8884-4e73-918a-6c0534fd66d8 access-control-expose-headers: Request-Context x-powered-by: ASP.NET set-cookie: ARRAffinity=36da0e643e19b219e9cc242244bbb17606f2f9cdc98871c377756b22cded58cb;Path=/;HttpOnly;Secure;Domain=www.bauschretinarx.com set-cookie: ARRAffinitySameSite=36da0e643e19b219e9cc242244bbb17606f2f9cdc98871c377756b22cded58cb;Path=/;HttpOnly;SameSite=None;Secure;Domain=www.bauschretinarx.com cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" server: cloudflare cf-ray: 6ce60e4c9bb75c38-FRA |
bauschretinarx.com Whois Information
Domain Name: BAUSCHRETINARX.COM Registry Domain ID: 2146259635_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-06-22T09:34:54Z Creation Date: 2017-07-24T15:16:48Z Registry Expiry Date: 2023-07-24T15:16:48Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.MARKMONITOR.COM Name Server: NS2.MARKMONITOR.COM Name Server: NS3.MARKMONITOR.COM Name Server: NS4.MARKMONITOR.COM Name Server: NS5.MARKMONITOR.COM Name Server: NS6.MARKMONITOR.COM Name Server: NS7.MARKMONITOR.COM DNSSEC: unsigned >>> Last update of whois database: 2022-01-16T07:54:05Z <<< |